Get these analyses to your inbox — https://axialfc.substack.com/ This is a newsletter for new financing events with some simple analysis. More well thought out work can be found at — https://axial.substack.com/
Axial invests and partners in early-stage life sciences companies. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company — info@axialsprawl.com
Life Sciences Financings and Commentary #10 — May 30, 2020 — June 5, 2020
Financings
Number of deals: 23 & Total capital invested: $1.17B
- Alpha Tau Medical raised $26M from Shavit Capital, Medison Ventures, and OurCrowd to develop their alpha-particle radiotherapies in oncology.
- Arterys raised $28M co-led by Temasek and Benslie Investment Group to scale up their cloud products for medical imaging. The business model is almost like Quantopian or Algorithmia for medical images: create a marketplaces of models to analyze patient data. Privacy is a big issue here.
- Athira Pharma raised $85M led by Perceptive Advisors to develop new medicines for Alzheimer’s (AD) and other CNS diseases. Their lead asset is in…
